Tymazoline
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
2-[(5-methyl-2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole | |
| Clinical data | |
| Trade names | Thymazen |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Nasal |
| Identifiers | |
| CAS Number |
24243-97-8 |
| ATC code | R01AA13 |
| PubChem | CID 34154 |
| DrugBank |
DB08803 |
| ChemSpider |
31478 |
| UNII |
U993RH5585 |
| KEGG |
D07373 |
| Chemical data | |
| Formula | C14H20N2O |
| Molar mass | 232.321 g/mol |
| |
| |
| | |
Tymazoline (trade name Thymazen in Poland) is a nasal decongestant that can be used to treat rhinitis. It acts as an antihistaminic and sympathomimetic, reducing swelling, inflammation and mucosal secretions.[1][2]
References
| ||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, October 13, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
